Monitoring in clinical biochemistry

Clinical Biochemist Reviews

Volumn 34, Issue 2, 2013, Pages 85-92

  Doust, Jenny ^a   Glasziou, Paul ^a  

^a BOND UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902009401     PISSN: 01598090     EISSN: 18380212     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Doll H, Shine B, Kay J, James T, Glasziou P. The rise ofcholesterol testing: how much is unnecessary. Br J GenPract 2011;61:e81-8.
2. Glasziou P, Irwig L, Mant D. Monitoring in chronicdisease: a rational approach. BMJ 2005;330:644-8.
3. Sidwell A, Barclay M, Begg E, Moore G. Digoxintherapeutic drug monitoring: an audit and review. N ZMed J 2003;116:U708.
4. Kristoffersen A-H, Thue G, Ajzner E, Claes N, Horvath AR, Leonetti R, et al. Interpretation and management of INR results: a case history based survey in 13 countries. Thromb Res 2012;130:309-15.
5. Liew SM, Doust J, Glasziou P. Cardiovascular risk scoresdo not account for the effect of treatment: a review. Heart 2011;97:689-97.
6. Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al; Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensivelowering of LDL cholesterol: a meta-analysis of datafrom 170,000 participants in 26 randomised trials. Lancet 2010;376:1670-81.
7. Department of Health and Ageing and University ofSouth Australia. Post Market Review, PharmaceuticalBenefits Scheme Products Used in the Treatment of Diabetes. Report to the Pharmaceutical Benefits AdvisoryCommittee. December 2012.
8. Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD. Self-monitoring of blood glucose inpatients with type 2 diabetes mellitus who are not usinginsulin. Cochrane Database Syst Rev 2012;1:CD005060.
9. Irwig L, Glasziou PP. Choosing the best monitoring tests. In: Glasziou PP, Irwig L, Aronson JK, editors. Evidence-Based Medical Monitoring: From Principles to Practice. Oxford, UK: Blackwell Publishing; 2008. p. 63-74.
10. Takahashi O, Glasziou PP, Perera R, Shimbo T, Suwa J, Hiramatsu S, et al. Lipid re-screening: what is the bestmeasure and interval? Heart 2010;96:448-52.
11. Johnson DW, Jones GR, Mathew TH, Ludlow MJ, Doogue MP, Jose MD, et al. Chronic kidney disease andautomatic reporting of estimated glomerular filtrationrate: new developments and revised recommendations. Med J Aust 2012;197:224-5.
12. Eriksen BO, Ingebretsen OC. In chronic kidney diseasestaging the use of the chronicity criterion affects prognosisand the rate of progression. Kidney Int 2007;72:1242-8.
13. Mant D, Hobbs FR, Glasziou P, Wright L, Hare R, Perera R, Price C, Cowie M. Identification and guided treatmentof ventricular dysfunction in general practice usingblood B-type natriuretic peptide. Br J Gen Pract. 2008 Jun;58(551):393-9.
14. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failureguided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-30.
15. Anderson JL, Horne BD, Stevens SM, Woller SC, Samuelson KM, Mansfield JW, et al. A randomized andclinical effectiveness trial comparing two pharmacogeneticalgorithms and standard care for individualizing warfarindosing (CoumaGen-II). Circulation 2012;125:1997-2005.
16. Gheorghiade M, van Veldhuisen DJ, Colucci WS. Contemporary use of digoxin in the management ofcardiovascular disorders. Circulation 2006;113:2556-64.
17. Westgard Web. http://www.westgard.com (Accessed 10 July 2013).
18. Takahashi O, Farmer AJ, Shimbo T, Fukui T, Glasziou PP. A1C to detect diabetes in healthy adults: when shouldwe recheck? Diabetes Care 2010;33:2016-7.
19. National Vascular Disease Prevention Alliance. Guidelines for the assessment of absolute cardiovasculardisease risk. 2009.
20. Lasserson DS, Buclin T, Glasziou P. How quickly shouldwe titrate antihypertensive medication? Systematicreview modelling blood pressure response from trial data. Heart 2011;97:1771-5.
21. Glasziou PP, Irwig L, Heritier S, Simes RJ, Tonkin A; LIPID Study Investigators. Monitoring cholesterollevels: measurement error or true change? Ann InternMed 2008;148:656-61.